Immunome logo

Immunome

A biotechnology company developing targeted and native human cancer antibodies

1

Funding Rounds

$12.2m

Money raised

Overview

A biotechnology company developing targeted and native human cancer antibodies

Funding series

Funding Series Analysis

The company Immunome has raised a total of $12.2m in funding over 1 rounds.

Key Insights:

  • Immunome Series A round, October 2016: $12.2m
Immunome logo
Immunome Series A round, October 2016 $12.2m

Industries

Immunome is active in the following industries: